Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-11-03
2008-07-29
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S304400
Reexamination Certificate
active
07405235
ABSTRACT:
Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing antibiotic resistance and inhibiting biofilms.
REFERENCES:
patent: 3325356 (1967-06-01), Di Netta et al.
patent: 3449498 (1969-06-01), de Stevens et al.
patent: 3549754 (1970-12-01), Di Netta et al.
patent: 3646049 (1972-02-01), Hoff et al.
patent: 3686110 (1972-08-01), Fisher et al.
patent: 3743738 (1973-07-01), Hoff et al.
patent: 5552426 (1996-09-01), Lunn et al.
patent: 5817793 (1998-10-01), Levy
patent: 5972995 (1999-10-01), Fischer et al.
patent: 6162393 (2000-12-01), De Bruiju et al.
patent: 6358978 (2002-03-01), Ritzeler et al.
patent: 3830697 (1990-03-01), None
patent: 0260744 (1988-08-01), None
patent: 0371559 (1990-06-01), None
patent: 0609963 (1994-08-01), None
patent: 0694535 (1996-01-01), None
patent: 5-25140 (1993-02-01), None
patent: 8-26991 (1996-01-01), None
patent: WO-98/06837 (1998-02-01), None
patent: WO-98/17267 (1998-04-01), None
patent: WO-98/37188 (1998-08-01), None
patent: WO-00/52144 (2000-09-01), None
patent: WO-2004/001058 (2003-12-01), None
Bouchet, et al (Bulletin de la Societe Chimique de France, vol. 1-2, Pt. 2, 1976, pp. 192-194, especially p. 193, Compound 5).
deStevens et al, J. Med. Chem., 1967, 10(2), 211-214, especially Table I, compound 14, p. 212.
Claims 116 and 173 of Co-pending U.S. Appl. No. 11/115,024 and Claim 51 of co-pending U.S. Appl. No. 10/602,562.
Heine, et al., (Tetrahedron Letters, No. 46, pp. 4801-4802, 1968, especially p. 4802, especially line 8).
deStevens, George, et al., “Derivatives of 1-Hydroxybenzimidazoles and 1-Hydroxyindoles and Their Central Depressant Effects,”Journal of Medicinal Chemistry, vol. 10(2):211-214 (1967).
Smirnov, L.D., et al., “Structure and Reactivity of 2-Methyl-9-Hydroxy-4H-Pyrido[1, 2-α]Pyrimidin-4-One,”Khimiya Geterotsiklicheskikh Soedinenii, pp. 1425-1431 (1991).
International Search Report Application No. PCT/US03/35205, dated Aug. 10, 2004.
Supplementary Partial European Search Report for Application No. 02807554.7-1216, Dated Nov. 7, 2007.
Alekshun Michael N.
Bhatia Beena
Bowser Todd
Grier Mark
Levy Stuart B.
Anderson Rebecca
Chung Susannah
Hanley, Esq. Elizabeth A.
Lahive & Cockfield LLP
Paratek Pharmaceuticals, Inc.
LandOfFree
Transcription factor modulating compounds and methods of use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transcription factor modulating compounds and methods of use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transcription factor modulating compounds and methods of use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3969123